Skip to Content

Nuveen International Eq Idx Retire TRIEX

Medalist Rating as of | See Nuveen Investment Hub
  • NAV / 1-Day Return 24.01  /  +1.18 %
  • Total Assets 25.2 Bil
  • Adj. Expense Ratio
    0.300%
  • Expense Ratio 0.300%
  • Distribution Fee Level Low
  • Share Class Type Retirement, Large
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment
  • Status Open
  • TTM Yield 2.68%
  • Turnover 8%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 11:32 PM GMT+0

Morningstar’s Analysis TRIEX

Will TRIEX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong management team and sound investment process underpin Nuveen International Eq Idx Retire's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TRIEX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 15.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

2.53 644.2 Mil
Healthcare

ASML Holding NV

2.19 557.0 Mil
Technology

Nestle SA

1.62 412.9 Mil
Consumer Defensive

AstraZeneca PLC

1.36 347.2 Mil
Healthcare

Shell PLC

1.33 337.2 Mil
Energy

Toyota Motor Corp

1.32 336.6 Mil
Consumer Cyclical

Lvmh Moet Hennessy Louis Vuitton SE

1.26 321.3 Mil
Consumer Cyclical

Msci Eafe Jun24 Ifus 20240621

1.19 301.8 Mil

Novartis AG Registered Shares

1.17 297.2 Mil
Healthcare

SAP SE

1.09 277.4 Mil
Technology